* Pertuzumab And Trastuzumab (updated 2024-12-01) ~ youtor.org

Pertuzumab And Trastuzumab (updated 2024-12-01)

Dr med Thomas Ruhstaller Kantonsspital St Gallen [upl. by Akeemahs]

Dr med Thomas Ruhstaller Kantonsspital St Gallen

Duration: 1:15
162 views | 10 Dec 2012

Outcomes from ADAPTHRHER2 evaluating dual HER2 blockade [upl. by Muire]

Outcomes from ADAPTHRHER2 evaluating dual HER2 blockade

Duration: 3:46
205 views | 10 Jun 2021

CLEOPATRA pertuzumab trastuzumab amp chemo for HER2 mBC [upl. by Fletcher834]

CLEOPATRA pertuzumab trastuzumab amp chemo for HER2 mBC

Duration: 2:40
2.7K views | 22 May 2020

AntibodyDrug Conjugates and Endometrial Cancer Combinations Response Rates and Clinical Trials [upl. by Larena]

AntibodyDrug Conjugates and Endometrial Cancer Combinations Response Rates and Clinical Trials

Duration: 27:34
112 views | 5 months ago

GMC ADMINISTERES 1ST PERTUZUMABTRASTUZUMAB INJECTION [upl. by Irod155]

GMC ADMINISTERES 1ST PERTUZUMABTRASTUZUMAB INJECTION

Duration: 2:02
1.3K views | 10 months ago

Remarkable data trastuzumab deruxtecan for HER2 BC [upl. by Ponce736]

Remarkable data trastuzumab deruxtecan for HER2 BC

Duration: 2:37
138 views | 22 May 2020

Martine Piccart Patients with HER2 positive breast cancer [upl. by Buckie460]

Martine Piccart Patients with HER2 positive breast cancer

Duration: 19:23
649 views | 28 Jan 2015

Optimizing HER2Positive Breast Cancer Therapy Balancing Efficacy and Toxicity [upl. by Arac]

Optimizing HER2Positive Breast Cancer Therapy Balancing Efficacy and Toxicity

Duration: 20:17
598 views | 3 months ago

Protocols for HER2Expressing GI Cancers Refining BTC and GEA Care With Targeted Agents [upl. by Clemence]

Protocols for HER2Expressing GI Cancers Refining BTC and GEA Care With Targeted Agents

Duration: 1:01:07
446 views | 21 Jun 2023

Report from 2011 San Antonio Breast Cancer Symposium DanaFarber Cancer Institute [upl. by Mita]

Report from 2011 San Antonio Breast Cancer Symposium DanaFarber Cancer Institute

Duration: 4:53
1.1K views | 8 Dec 2011

Dr Tolaney on Standard Frontline Treatment Approaches in HER2 Breast Cancer [upl. by Rednijar]

Dr Tolaney on Standard Frontline Treatment Approaches in HER2 Breast Cancer

Duration: 1:39
74 views | 3 months ago

침윤성 유방암 3 기 2 차 항암 후유증 [upl. by Carlstrom]

침윤성 유방암 3 기 2 차 항암 후유증

Duration: 16:35
13.1K views | 4 Dec 2020

Dr Felipe Ades Câncer de mama HER2 positivo e seus tratamentos [upl. by Rdnaskela]

Dr Felipe Ades Câncer de mama HER2 positivo e seus tratamentos

Duration: 4:14
36K views | 19 Oct 2017

Breast Cancer Signs Symptoms and Treatment [upl. by Auqenes]

Breast Cancer Signs Symptoms and Treatment

Duration: 5:04
33.6K views | 5 months ago

INNOVATION chemotherapy with trastuzumab and pertuzumab in HER2 gastric cancer [upl. by Oetsira]

INNOVATION chemotherapy with trastuzumab and pertuzumab in HER2 gastric cancer

Duration: 8:01
463 views | 11 Jul 2023

Breast Cancer Stages Luminal A amp Luminal B Breast Cancer amp TreatmentDrSwaroop R Doctors Circle [upl. by Lewendal385]

Breast Cancer Stages Luminal A amp Luminal B Breast Cancer amp TreatmentDrSwaroop R Doctors Circle

Duration: 2:43
1.1K views | 1 month ago

Tumore al seno metastatico HER2 con pertuzumab e trastuzumab una paziente su tre in vita a 8 anni [upl. by Nomad]

Tumore al seno metastatico HER2 con pertuzumab e trastuzumab una paziente su tre in vita a 8 anni

Duration: 4:22
5.9K views | 13 Jun 2019

NRGGY026 [upl. by Venice]

Duration: 2:27
540 views | 20 Feb 2023

Rapid fire Session 2 Mini Oral Presentations [upl. by Nymzaj492]

Rapid fire Session 2 Mini Oral Presentations

Duration: 39:40
450 views | 8 months ago

Episode 338 HighVolume Subcutaneous Injections The Oncology Nurse’s Role [upl. by Ainedrag823]

Episode 338 HighVolume Subcutaneous Injections The Oncology Nurse’s Role

Duration: 25:33
63 views | 1 week ago

Dr Felipe Ades Estudo APHINITY com Pertuzumab para câncer de mama HER2 positivo [upl. by Vincenz]

Dr Felipe Ades Estudo APHINITY com Pertuzumab para câncer de mama HER2 positivo

Duration: 4:25
1.9K views | 2 Oct 2017

The Potential of HER2 HER3 and TROP2Targeted Therapies to Address Unmet Needs in Advanced NSCLC [upl. by Arracot470]

The Potential of HER2 HER3 and TROP2Targeted Therapies to Address Unmet Needs in Advanced NSCLC

Duration: 58:30
992 views | 8 Oct 2021

Pertuzumab Perjeta Injection Uses Dosage Mechanism Side Effects and Important Advice [upl. by Harutak]

Pertuzumab Perjeta Injection Uses Dosage Mechanism Side Effects and Important Advice

Duration: 4:05
78 views | 5 months ago

FISH HER2 ERBB2 AMPLIFICATION [upl. by Kurys]

FISH HER2 ERBB2 AMPLIFICATION

Duration: 2:03
4 views | 5 months ago

Früher Brustkrebs Hormonrezeptorpositiv HER2positiv ESMO 2024 [upl. by Ran]

Früher Brustkrebs Hormonrezeptorpositiv HER2positiv ESMO 2024

Duration: 23:57
131 views | 1 month ago

Cor4Unottreated – ID 100418 [upl. by Leeke508]

Cor4Unottreated – ID 100418

Duration: 0:26
33 views | 10 Apr 2018

ABP 980 a trastuzumab biosimilar in combination with pertuzumab [upl. by Myk865]

ABP 980 a trastuzumab biosimilar in combination with pertuzumab

Duration: 3:14
1.7K views | 25 Mar 2021

Study of Atezolizumab with Pertuzumab and Trastuzumab in HER2 Positive Metastatic Breast Cancer [upl. by Alberto849]

Study of Atezolizumab with Pertuzumab and Trastuzumab in HER2 Positive Metastatic Breast Cancer

Duration: 4:31
3.1K views | 23 Aug 2019

Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival outcomes in HR and HE [upl. by Ecnal967]

Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival outcomes in HR and HE

Duration: 5:58
25 views | 2 months ago

Dr Tarantino on Updated Survival Data With TDXd in HER2 Breast Cancer [upl. by Acinorrev109]

Dr Tarantino on Updated Survival Data With TDXd in HER2 Breast Cancer

Duration: 2:02
154 views | 5 months ago

Our site allows you to download your favorite videos in MP3 (audio) or MP4 (video) format in the most efficient way. You can find your favorite videos using "search" to download them.

New on site

Content Report
youtor.org / Youtor Videos converter © 2024